3Leconte M, Nicco C, Ng6 C, et al. The mTOR/AKT inhibitor temsirolimus prevents deep infiltrating endometriosis in mice [J]. Am J Pathol, 2011, 179 (2) : 880 -889.
4Hresko RC, Mueckler M. mTOR. RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3 -L1 adipocytes [J]. J Biol Chem, 2005, 280 (49): 40406-40416.
5Vander Haar E, Lee SI, Bandhakavi S, et al. Insulin signa- ling to mTOR mediated by the Akt/PKB substrate PRAS40 [J]. Nat Cell Biol, 2007, 9 (3) : 316 -323.
6Bat X, Ma D, Liu A, et al. Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38 [J]. Science, 2007, 318 (5852): 977-980.
7Proud CG. Signaling to translation: how signal transduction pathways control the protein synthetic machinery [J]. Biochem J, 2007, 403 (2): 217-234.
9Steelman LS, Abrams SL, Whelan J, et al. Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/ STAT pathways to leukemia[J]. Leukemia, 2008, 22 (4) : 686 - 707.
10Jacot JL, Sherris D. Potential therapeutic roles for inhibition of the PI3K/Akt/mTOR pathway in the pathophysiology of di- abetic retinopathy [J]. J Ophthalmol, 2011, 2011: 589813.
5Bomback AS,Klemmer PJ.Interaction of aldosterone and extracellular volume in the pathogenesis of obesity-associated kidney disease:a narrative review.Am J Nephrol,2009,30:140-146.
6Anderson S,Komers R.Inhibition of the renin-angiotensin system:is more better?Kidney Int,2009,75:12-14.
7Zhang A,Jia Z,Guo X,et al.Aldosterone induces epithelial-mesenchymal transition via ROS of mitochondrial origin.Am J Physiol Renal Physiol,2007,293:F723-F731.
9Zhang A,Wang MH,Dong Z,et al.Prostaglandin E2 is a potent inhibitor of epithelial-to-mesenchymal transition:interaction with hepatecyte growth factor.Am J Physiol Renal Physiol,2006,291:F1323-F1331.
10Ding G,Zhang A,Huang S,et al.ANG II induces x-Jun NH2-terminal kinase activation and proliferation of human mesangial cells via redox-sensitive transactivation of the EGFR.Am J Physiol Renal Physiol,2007,293:F1889-F1897.
